FDA Warns Doctors After 19 Deaths on Intercept Liver Drug
- Some patients died after taking excessive doses, agency says
- Drugmaker stock drops almost 25 percent, the most since 2014
This article is for subscribers only.
Nineteen patients died after taking a liver-disease drug from Intercept Pharmaceuticals Inc., the U.S. Food and Drug Administration said, warning doctors about risks from a product that the company is seeking to make into a blockbuster.
Shares of the drugmaker sank 24.9 percent to $73.70 at 4:00 p.m. in New York, the company’s biggest loss since November 2014.